Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey

AstraZeneca logo

AstraZeneca

Status

Completed

Conditions

Bipolar Disorder

Study type

Observational

Funder types

Industry

Identifiers

NCT00660712
NIS-NTR-DUM-2007/1

Details and patient eligibility

About

A registry study to identify the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.

Enrollment

1,018 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients previously or currently diagnosed with bipolar disorder
  • Patients (or any of their relatives) who give a written informed consent.

Exclusion criteria

Patients who were previously included in this study.

Trial design

1,018 participants in 1 patient group

1
Description:
Patients with bipolar disorder

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems